These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10714913)

  • 21. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.
    Neele SJ; Evertz R; De Valk-De Roo G; Roos JC; Netelenbos JC
    Bone; 2002 Apr; 30(4):599-603. PubMed ID: 11934652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial.
    Marcus R; Greendale G; Blunt BA; Bush TL; Sherman S; Sherwin R; Wahner H; Wells B
    J Bone Miner Res; 1994 Sep; 9(9):1467-76. PubMed ID: 7817832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss.
    Aloia JF; Vaswani A; Yeh JK; Ross PL; Flaster E; Dilmanian FA
    Ann Intern Med; 1994 Jan; 120(2):97-103. PubMed ID: 8256988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.
    Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Chansirikarn S; Puavilai G; Rajatanavin R
    Maturitas; 2002 Feb; 41(2):149-56. PubMed ID: 11836046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol.
    Ushiroyama T; Ikeda A; Sakai M; Higashiyama T; Ueki M
    Maturitas; 2003 Jun; 45(2):119-27. PubMed ID: 12787970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
    Masud T; Mulcahy B; Thompson AV; Donnelly S; Keen RW; Doyle DV; Spector TD
    Ann Rheum Dis; 1998 Jun; 57(6):346-9. PubMed ID: 9771208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
    Civitelli R; Pilgram TK; Dotson M; Muckerman J; Lewandowski N; Armamento-Villareal R; Yokoyama-Crothers N; Kardaris EE; Hauser J; Cohen S; Hildebolt CF
    Arch Intern Med; 2002 Jun; 162(12):1409-15. PubMed ID: 12076241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
    Duan Y; Tabensky A; DeLuca V; Seeman E
    Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
    Greenspan SL; Resnick NM; Parker RA
    JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of daily hormone therapy and alendronate use on bone mineral density in postmenopausal women.
    Davas I; Altintas A; Yoldemir T; Varolan A; Yazgan A; Baksu B
    Fertil Steril; 2003 Sep; 80(3):536-40. PubMed ID: 12969694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women.
    Prestwood KM; Gunness M; Muchmore DB; Lu Y; Wong M; Raisz LG
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2197-202. PubMed ID: 10852452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of low-dose or standard-dose conjugated equine estrogen combined with different progesterone on bone density in menopause syndrome women].
    Zuo HL; Deng Y; Wang YF; Gao LL; Xue W; Zhu SY; Ma X; Sun AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):243-247. PubMed ID: 29747269
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.
    Greendale GA; Espeland M; Slone S; Marcus R; Barrett-Connor E;
    Arch Intern Med; 2002 Mar; 162(6):665-72. PubMed ID: 11911720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women.
    Ziller M; Herwig J; Ziller V; Kauka A; Kostev K; Hadji P
    Gynecol Endocrinol; 2012 Dec; 28(12):1002-5. PubMed ID: 22835159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.